Evidence map›Paper›PMID 38266095›Full record

ArticleScience advances2024

CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice.

María Latorre-Leal, Patricia Rodriguez-Rodriguez, Luca Franchini, Orestis Nikolidakis, Makrina Daniilidou, Ljerka Delac, Mukesh K Varshney, Luis E Arroyo-García, Francesca Eroli, Bengt Winblad and 12 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Translational perspectives on women's mental health.The British journal of psychiatry : the journal of mental science · 2025
    Article
  9. Review
  10. Article
  11. GnRH and Cognition.Endocrinology · 2025
    Review
  12. Article
  13. Review
  14. Sex, senescence, senolytics, and cognition.Frontiers in aging neuroscience · 2025
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 5 countries.

María Latorre-LealDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-8434-3822
Patricia Rodriguez-RodriguezDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2438-3515
Luca FranchiniDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Orestis NikolidakisDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0009-0006-2685-8736
Makrina DaniilidouDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Ljerka DelacDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1840-1710
Mukesh K VarshneyDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2165-0152
Luis E Arroyo-GarcíaDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9206-0179
Francesca EroliDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Bengt WinbladDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0011-1179
Kaj BlennowInstitute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.ORCID 0000-0002-1890-4193
Henrik ZetterbergInstitute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.ORCID 0000-0003-3930-4354
Miia KivipeltoDepartment of Neurobiology Care Sciences and Society, Division of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0992-3875
Manuela PacciariniSwansea University Medical School, SA2 8PP Swansea, UK.
Yuqin WangSwansea University Medical School, SA2 8PP Swansea, UK.ORCID 0000-0002-3063-3066
William J GriffithsSwansea University Medical School, SA2 8PP Swansea, UK.ORCID 0000-0002-4129-6616
Ingemar BjörkhemDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Anna MattonDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-7819-0495
Ivan NalvarteDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6828-2583
Paula Merino-SerraisDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-1842-9476
Angel Cedazo-MinguezDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4626-4864
Silvia MaioliDepartment of Neurobiology Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9577-0803
Karolinska Institutet · SESwansea University · GBInstituto Cajal · ESKarolinska University Hospital · SESahlgrenska University Hospital · SEUniversity of Science and Technology of China · CN

Funding

Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease riskR01AG065209 · NIA · KAROLINSKA INSTITUTE · PI NALVARTE, IVAN · 2020 to 2023
$1.8M
NIA NIH HHS R01 AG065209
6 · The paper itself

Abstract

The brain-specific enzyme CYP46A1 controls cholesterol turnover by converting cholesterol into 24

Indexed as

Alzheimer DiseaseMemory DisordersAgedAnimalsCholesterolCholesterol 24-HydroxylaseCognitionEstrogensFemaleHumansMaleMiceCholesterolCholesterol 24-HydroxylaseEstrogens

Identifiers

PMID38266095
PMCPMC10807813
OpenAlexW4391205677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.